Global trends in cutaneous malignant melanoma incidence and mortality

Abstract

Mortality from cutaneous malignant melanoma (CMM) increased in the past, but trends have been favorable in more recent years in many high-income countries. However, incidence has been increasing in several countries. We provided an up-to-date overview of mortality trends from CMM. We analyzed death certification data from the WHO in selected countries worldwide from 1980 to the most recent available calendar years. We also reported incidence data derived from Cancer Incidence in Five Continents from 1990 to 2012. Separate analyses were performed for young adults aged 20-44 and middle-aged adults aged 45-64 years. Mortality from CMM in all age groups showed a favorable pattern in the majority of the countries considered. Mortality trends declined by 40 to 50% in Australia over the last decades, confirming the importance of prevention measures. Considering young adults aged 20-44, Australia, New Zealand and Northern Europe reported the highest death rates for both sexes (>0.90/100 000 in men and >0.60/100 000 in women) while Japan, the Philippines, and Latin America the lowest ones (<0.50/100 000 and <0.35/100 000 in men and women, respectively). Incidence trends were stable or upward in most countries, with higher rates among women. Our study highlights a global reduction of CMM mortality over the last three decades. The increasing awareness of risk factors, mainly related to UV exposure, along with early diagnosis and progress in treatment for advanced disease played pivotal roles in reducing CMM mortality, particularly in Australia.

Fig. 1

Trends in age-standardized (world population) mortality rates (dots) per 100 000 persons and corresponding joinpoint models (lines) for cutaneous malignant melanoma in selected major countries worldwide, among men (black) and women (gray) aged 20–44.

Fig. 2

Trends in age-standardized (world population) mortality rates (dots) per 100 000 persons and corresponding joinpoint models (lines) for cutaneous malignant melanoma in selected major countries worldwide, among men (black) and women (gray) aged 45–64.

Fig. 3

Annual age-standardized incidence rates from melanoma skin cancer per 100 000 in selected worldwide countries among men (black) and women (gray) aged 20–44.

Fig. 4

Annual age-standardized incidence rates from melanoma skin cancer per 100 000 in selected worldwide countries among men (black) and women (gray) aged 45–64.